Publications by authors named "Martin Bopst"

Claim this Profile
S
Safety, pharmacokinetics, and pharmacodynamics of the antisense oligonucleotide RO7239958 in healthy volunteers and adults with chronic hepatitis B infection.
Anna Maria Geretti, Alexandre Sostelly, Simon Buatois, Sijie Lu, Annabelle Lemenuel, Martin Bopst

Antimicrob Agents Chemother· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unexpected neurotoxicity in chronic toxicity studies with a HBV viral expression inhibitor.
Martin Bopst, Theo Dinklo, Juergen Funk, Andrea Greiter-Wilke, Barbara Lenz

Regul Toxicol Pharmacol· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An innovative investigative approach to characterize the effects observed in a combined fertility study in male and female rats.
Jianxun Xie, Juergen Funk, Martin Bopst, Giorgio Ottaviani, Noel Downes

Regul Toxicol Pharmacol· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modern science for better quality control of medicinal products "Towards global harmonization of 3Rs in biologicals": The report of an EPAA workshop.
Katrin Schutte, Anna Szczepanska, Marlies Halder, Klaus Cussler, Ursula G Sauer, Martin Bopst

Biologicals· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Non-clinical safety evaluation and risk assessment to human of aleglitazar, a dual PPAR α/γ agonist, and its major human metabolite.
Martin Bopst, Elke-Astrid Atzpodien

Regul Toxicol Pharmacol· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potential confounding effects of benzyl alcohol as a formulation excipient support the elimination of the abnormal toxicity test from pharmacopoeias.
Jianxun Xie, Giorgio Ottaviani, Kai Sun, Mingqiu Lu, Xiaoqin Wu, Martin Bopst

Regul Toxicol Pharmacol· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Minireview: Challenges and opportunities in development of PPAR agonists.
Matthew B Wright, Michele Bortolini, Moh Tadayyon, Martin Bopst

Mol Endocrinol· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Historical data analyses and scientific knowledge suggest complete removal of the abnormal toxicity test as a quality control test.
Joerg H O Garbe, Susanne Ausborn, Claire Beggs, Martin Bopst, Angelika Joos

J Pharm Sci· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Examining the safety of PPAR agonists - current trends and future prospects.
Michele Bortolini, Matthew B Wright, Martin Bopst, Bogdana Balas

Expert Opin Drug Saf· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis